Using a connected watch to record ECG traces
Feasibility and Diagnostic Relevance of Recording an ECG Trace With a Connected Watch
This study is testing if a connected watch can accurately record heart activity compared to traditional heart monitors in people with different heart conditions.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 3000 (estimated) |
| Sex | All |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 1 site (Pessac) |
| Trial ID | NCT06272396 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of ECG recordings from a connected watch compared to standard 12-lead ECGs in patients with various heart conditions. It aims to assess the sensitivity of 1D and 6D ECG recordings in measuring electrical parameters of the heart. Additionally, the study will create a database of ECG tracings to develop and validate an artificial intelligence algorithm for automatic ECG analysis. The participants will include both healthy individuals and those with arrhythmias or other cardiac issues.
Who should consider this trial
Good fit: Ideal candidates include patients hospitalized or consulted at the Haut Lévêque cardiology hospital, regardless of age, who can provide informed consent.
Not a fit: Patients who are unable to give consent or are under legal protection measures will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance remote monitoring of heart conditions, leading to quicker and more accurate diagnoses.
How similar studies have performed: Other studies have shown promise in using wearable technology for ECG monitoring, indicating a growing interest and potential in this area.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients hospitalized or seen in consultation in one of the departments of the Haut Lévêque cardiology hospital, * Patient of both sexes, minor (from birth to 18 years) or adult, * Free, informed and written consent from the patient or, in the case of minors, from the legal parent (at the latest on the day of inclusion and before any examination required for the research), * Subject affiliated to or benefiting from a social security regime. Exclusion Criteria: * Person incapable of giving consent, * Person subject to a legal protection measure (safeguard of justice, tutorship or curatorship), * A person deprived of liberty by judicial or administrative decision.
Where this trial is running
Pessac
- Hôpital Haut-Lévèque — Pessac, France (Recruiting)
Study contacts
- Principal investigator: Pierre BORDACHAR — University Hospital, Bordeaux
- Study coordinator: Pierre BORDACHAR
- Email: pierre.bordachar@chu-bordeaux.fr
- Phone: +335 57 65 64 71
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.